{"id":"W2322800322","doi":"10.1136/annrheumdis-2013-eular.2606","title":"AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Internal medicine; Safety profile; Adverse effect; Rheumatoid arthritis; Physical therapy; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002467762,0.001027421,0.003178705,0.0003627329,0.0004173327,0.001431037,0.0006902757,0.00143715,0.003830904],"category_scores_gemma":[0.003521275,0.0003501732,0.003089732,0.0005034594,0.000846187,0.001218689,0.0004344706,0.003422476,0.0009155531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004981079,"about_ca_system_score_gemma":0.0009860012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005173023,"about_ca_topic_score_gemma":0.0007089738,"domain_scores_codex":[0.9987782,0.0006886785,0.00009034848,0.0001533699,0.0001236522,0.0001656744],"domain_scores_gemma":[0.9969677,0.001064811,0.0008377429,0.0003706602,0.0002116506,0.0005473551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9516674,0.002350583,0.002277452,0.0004891289,0.002243866,0.00006615964,0.00005655556,0.0004037053,0.004290468,0.0001018823,0.001084271,0.03496858],"study_design_scores_gemma":[0.6965977,0.2560881,0.03202501,0.0002238505,0.006226237,0.0002775929,0.0001353346,0.001022489,0.002827206,0.0007605093,0.00374933,0.00006668505],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784415,0.01392706,0.0007481476,0.0009763697,0.0003761222,0.0004633074,0.002011853,0.000160127,0.002895321],"genre_scores_gemma":[0.9916863,0.002941022,0.0005571062,0.000928143,0.0005747044,0.0003708274,0.001564298,0.00003693262,0.001340658],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003830904,"threshold_uncertainty_score":0.01305097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04319033244244259,"score_gpt":0.3280958714096306,"score_spread":0.284905538967188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}